O PROTIVOVOSPALITEL'NYKh SVOYSTVAKh MAKROLIDOV
- Authors: FISENKO V1, ChIChKOVA N1
-
Affiliations:
- Issue: Vol 5, No 2 (2005)
- Pages: 56-58
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/117588
- ID: 117588
Cite item
Abstract
References
- Цветкова О. Макролиды в терапии внебольничной пневмонии и обострений ХОБЛ. // Врач. - 2004. - № 6. - С. 50-53.
- Basygyt I., Yildiz F., Ozkara S.K. et al. The effect of claritromycin on inflammatory markers in chronic obstructive pulmonary disease. Preliminary data. // The Annals of pharmacotherapy. - 2004. - V. 38. - P. 17-23.
- Cuffini A.M., Tullio V., Mandras N. et al. Claritromycin mediated the expression of polymorphonuclear granulocyte response against Streptococcus pneumoniae strains with different patterns of subceptibility and resistance to penicillinum and claritromycin. // Int. J. Tissue React. - 2002. - V. XXIV, № 1 - Р. 37-44.
- Dorca J., Padrones S., Manresa F. Macrolides and lower respiratory infections. // Europ. Respir. Monogr. - 2004. - V. 9. - № 28. - Р. 78-93.
- Ferrara G., Losi M., Franco F et al. // Macrolides in the treatment of asthma and cystic fibrosis. // Respiratory Med. - 2005. - V. 99. - P. 1-10.
- Gotfried M.H. Macrolides for the treatment of chronic sinusitis,asthma and COPD. // Chest - 2004. - V.125. - Suppl. - P. 52S-61S.
- Hatipoglu U., Rubinstein I. Low-dose, long-term macrolide therapy in asthma: An overview. // Clin. Molecul. Allergy. - 2004. - V. 2. - № 4. - Р. 12-17.
- Kanai K., Asana K., Hisamitsu T. // Europ. Respir. J. - 2004. - V. 23. - P. 671-678.
- Kostadima E., Tsiodras S., Alexopoulos E.I. et al. // Europ. Respir. J. - 2004. - V. 23 - P. 714-717.
- Kraft M., Cassel G.H., Pak J. et al. // Chest. - 2002. - V. 121. - P. 1782-1788.
- Labro M.T. Antibiotics as anti-inflammatory drugs. // Curr. Op. Investig. Drugs. - 2002. - V. 3. - P. 61-68.
- Labro M.T. Interaction of antibacterial agents with host respiratory defences. // Europ. Respir. Monogr. - 2004 - V. 9. - № 28. - Р. 45-63.
- Rubin B., Henke M.O. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease. // Chest. - 2004. - V. 125. Suppl. - P. 70S-78S.
- Tamaoki J. The effects of macrolides on inflammatory cells. // Chest. - 2004. - V. 125. - Suppl. - P. 41S-51S.
- Ives T.J. // Research communication in molecular pathology and pharmacology. - 2001. - V. 110 (3-4). - P. 83-208.
- Morikawa K. et. al. // International Journal of antimicrobial agents. -2002, January. - V. 191. - P. 53-59.